Comparison of two strategies of glucocorticoid withdrawal in patients with rheumatoid arthritis in low disease activity (STAR): a randomised, placebo-controlled, double-blind trialAdeline Ruyssen-Witrand, Clara Brusq, Maëva Masson, Vanina Bongard, Carine Salliot, Lucile Poiroux, Minh Nguyen, Christian Hubert Roux, Christophe Richez, Alain Saraux, Pascale Vergne-Salle, Jacques Morel, René-Marc Flipo, Muriel Piperno, Jacques-Eric GottenbergSee the full list of authors
29 October 2024
Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatmentEugen Feist, Roy M Fleischmann, Saeed Fatenejad, Daria Bukhanova, Sergey Grishin, Sofia Kuzkina, Michael Luggen, Evgeniy Nasonov, Mikhail Samsonov, Josef S Smolen
2 July 2024
Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsivenessSatoshi Kubo, Yusuke Miyazaki, Takahiro Nishino, Yuya Fujita, Michihiro Kono, Tsugumi Kawashima, Kazuyoshi Ishigaki, Katsuhide Kusaka, Hiroaki Tanaka, Masanobu Ueno, Yurie Satoh-Kanda, Yoshino Inoue, Yasuyuki Todoroki, Ippei Miyagawa, Kentaro HanamiSee the full list of authors
4 October 2024
Association of methotrexate polyglutamates concentration with methotrexate efficacy and safety in patients with rheumatoid arthritis treated with predefined dose: results from the MIRACLE trialHiroya Tamai, Kei Ikeda, Toshiaki Miyamoto, Hiroaki Taguchi, Chang-Fu Kuo, Kichul Shin, Shintaro Hirata, Yutaka Okano, Shinji Sato, Hidekata Yasuoka, Masataka Kuwana, Tomonori Ishii, Hideto Kameda, Toshihisa Kojima, Yurie NishiSee the full list of authors
4 October 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome setPhilip Rask Lage-Hansen, Nikoletta Svendsen, Jamie Kirkham, Sabrina Mai Nielsen, Kirstine Amris, Maarten de Wit, Maarten Boers, Torkell Ellingsen, Robin Christensen
22 May 2024
NAT10 promotes synovial aggression by increasing the stability and translation of N4-acetylated PTX3 mRNA in rheumatoid arthritisDi Liu, Yu Kuang, Simin Chen, Ruiru Li, Fan Su, Shuoyang Zhang, Qian Qiu, Shuibin Lin, Chuyu Shen, Yingli Liu, Liuqin Liang, Jingnan Wang, Hanshi Xu, Youjun Xiao
8 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 yearsGerd R Burmester, Jacques-Eric Gottenberg, Roberto Caporali, Kevin L Winthrop, Yoshiya Tanaka, Edmund V Ekoka Omoruyi, Vijay Rajendran, Paul Van Hoek, Katrien Van Beneden, Tsutomu Takeuchi, René Westhovens, Daniel Aletaha
23 May 2024
Disease activity of rheumatoid arthritis and kidney function decline: a large prospective registry studySho Fukui, Wolfgang C Winkelmayer, Sara K Tedeschi, Javier Marrugo, Hongshu Guan, Leslie Harrold, Heather J Litman, Tomohiro Shinozaki, Daniel H Solomon
21 August 2024
Altered serum metabolome as an indicator of paraneoplasia or concomitant cancer in patients with rheumatic diseaseKarolina Gente, Manuel Feisst, Dorothea Marx, Karel D Klika, Petros Christopoulos, Jürgen Graf, Julia Will, Thomas Luft, Jessica C Hassel, Carsten Müller-Tidow, Rui A Carvalho, Hanns-Martin Lorenz, M Margarida Souto-Carneiro
1 April 2024
Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machineryPang Lyu, Jinming Wen, Wenshuo Zhang, Ning Liu, Iris Stolzer, Andreas Gießl, Yewei Jia, Daniele Mauro, Fulin Zhang, Francesco Ciccia, Didier Soulat, Claudia Günther, Georg Schett, Aline Bozec
19 March 2024
